PRSS2 and acute pancreatitis: Thus, while the observed trends are consistent with the known pathophysiology of acute pancreatitis—namely, a reduction in early enzymatic activation (TAP) and ongoing tissue injury (trypsin-2) they require confirmation in adequately powered prospective studies.